Label reads in part "***CASCADE GLACIER CHOCOLATE PEANUT BUTTER ***3 GALLONS (11.36 l) Plant 41-90 DISTRIBUTED BY OREGON ICE CREAM CO. EU...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0318-2013.
The products are being recalled because they contain peanut butter associated with the Sunland, Inc. recall and have the potential to be contaminated with Salmonella.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0318-2013.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Oregon Ice Cream, Llc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0318-2013.
Oregon Ice Cream, LLC
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Oregon Ice Cream, Llc Recall FAQ
Oregon Ice Cream, Llc is the subject of a dairy safety report: Label reads in part "***CASCADE GLACIER CHOCOLATE PEANUT BUTTER ***3 GALLONS (11.36 l) Plant 41-90 DISTRIBUTED BY OREGON ICE CREAM CO. EU.... The notice was published on September 27, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 8,830 units are potentially affected.